Interní Med. 2007; 9(6): 268-272

Diabetes mellitus and thyroid disorders

prof. MUDr. Václav Zamrazil DrSc1,2, doc. MUDr. Karel Vondra DrSc1,2
1 Endokrinologický ústav, Praha
2 Subkatedra endokrinologie IPVZ Praha

Combination of diabetes mellitus (DM) and thyroid disease (TD) is more frequent than their prevalence in general population (5–7 percents). DM is found in 10–20 % patients with TD, in Graves thyrotoxicosis in 20–25 percent. The effective treatment is normalization of thyroid function, that can prevent in early stage the development of permanent DM. In diabetic patients TD is frequent in autoimmune DM (DM 1, LADA) the autoimmune TD prevails (chronic autoimmune thyroiditis). Pathalogic changes of thyroid function (hypo – and/or hyperthyroidism) impair metabolic compensation of DM and increase a risk of its complications. Most important is combination of DM and TD in pregnancy, where it is dangerous for both health status of mother and development of fetus.

Keywords: diabetes mellitus (DM), thyroid disorders, chronic thyroiditis, hypothyroidism, hyperthyroidism, pregnancy

Published: November 9, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zamrazil V, Vondra K. Diabetes mellitus and thyroid disorders. Interní Med. 2007;9(6):268-272.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Al Refxi H, Allabahidi H, Lewy S. Review: endocrinne system in diabetes mellitus. Endocrinology 2002; 18: 105-109. Go to original source...
    2. Běhanová M, Zamrazil V, Vondra K, et al. Klinická charakteristika tyreopatií u diabetiků středního věku, DMEV 1999; 2 (Suppl 1): 21-22.
    3. Hansen J, et al. A prospective study of thyroid function morphology and autoimmunity in young patients with type 1 diabetes Eur J Endocrinol 2003; 138: 245-251. Go to original source... Go to PubMed...
    4. Chodová J, Zamrazil V Jr, Piťhová P. Hypoglykemické koma jako důsledek poklesu spotřeby inzulinu při nediagnostikované hypotyreóze. Kazuistiky v diabetologii 2003; 1: 30-31.
    5. Kordonouri O, Klinghammer A, Lang EB, et al: Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter study. Diabetes Care 2002; 25: 1346-1350. Go to original source... Go to PubMed...
    6. Mandel S. Diagnostics and treatment of thyroid disease during pregnancy s. 3437-3460 in Endocrinology 5 vyd. DeGroot LJ, Jameson JL (eds), Elsevier, Philadelphia, 2006.
    7. Matějková-Běhanová M, Zamrazil V, Vondra K, et al. Autoimmune thyroiditis in non-obese subjects with initial diagnosis of type 2 diabetes mellitus. J Endocrinol Invest 2002; 25: 779-784. Go to original source... Go to PubMed...
    8. Metzger BE, Purdy LP, Phelps RL. Diabetes mellitus and pregnancy s. 3419-3435 v Endocrinology, 5. vyd. DeGroot LJ, Jameson JL (eds) Elsevier, Phildelphia, 2006.
    9. Mohn A, DiMichele S, Di Luzio R. The effect of subclinical hypothyroidism on metabolic control in children and adults with type 1 diabetes mellitus. Diabet Med 2002; 19: 70-73. Go to original source... Go to PubMed...
    10. Perros P, McCrimmon RJ, Shaw G, et al. Frequency of thyroid dysfunction in diabetic patients: value of annual secreting. Diabet Med 1995; 12: 622-627. Go to original source... Go to PubMed...
    11. Rybka J. Algoritmus farmakoterapie hyperglykemie u diabetika. Interní medicina pro praxi 2007; 1: 42-46.
    12. Stanická S, Vondra K, Pelikánová T, et al. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during replacement therapy. Clin Chem Lab Med 2005; 43: 715-720. Go to original source... Go to PubMed...
    13. Steiss JO, Otlen A, Graef V, et al: Thyroid gland ultrasond and urinary iodine excretion in children and adolescents with diabetes mellitus, 1966; 208: 327-333.
    14. Umpierre GE, Latif KA, Murphy MB, et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Case 2003; 26: 1181-1185. Go to original source... Go to PubMed...
    15. Vondra K, Vrbíková J, Bendlová B, et al. Differences in type 1 diabetes mellitus of young adults with and without thyroid autoimmunity. Exp Clin Endocrinol Diabetes 2005; 113: 404-408. Go to original source... Go to PubMed...
    16. Vondra K, Vrbíková J, Šterzl I. Tyreoidální autoimunita u dospělých diabetiků 1. typu. Vlastní zkušenosti z 11letého sledování. Vnitřní Lék 2006; 52: 864-872.
    17. Vondra K, Zamrazil V. Endokrinní systém a diabetes mellitus s. 353-366 in Endokrinologie interdisciplinární obor, Blahoš J, Zamrazil V (eds), Triton, Praha, 2006.
    18. Vondra K, Zamrazil V. Onemocnění štítné žlázy u diabetiků s. 31-48 in Trendy soudobé diabetologie sv. 9, Perušičová J (ed), Galén, Praha, 2004.
    19. Zamrazil V, Vondra K. Štítná žláza a diabetes s. 407-422 in Praktická diabetologie, 3. vyd., Bartoš V, Pelikánová T (ed), Maxdorf Jessenius, Praha, 2003.
    20. Zamrazil V, Vondra K. Endokrinní onemocnění u diabetiků s. 13-28 in Trendy soudobé diabetologie sv. 9, Perušičová J (ed) Galén, Praha, 2004.
    21. Zamrazil V. Diabetes mellitus a onemocnění štítné žlázy. Thomayerova sbírka 505, Avicenum, Praha 1986: 83-183.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.